In memoriam Michael Goldman (1936 - 2010) Paredi P., Usmani O.S., Kharitonov S.A., Siafakas N.M., Pride N.B., Barnes P.J. Eur Respir J 2010; 36: 977-978 | |
Finding the way through the respiratory symptoms jungle: PAL can help Van den Boom M., Seita A., Ottmani S., Migliori G.B. Eur Respir J 2010; 36: 979-982 | |
Prudent use of antibiotics: acute exacerbation of COPD as an example Rohde G.G.U. Eur Respir J 2010; 36: 983-985 | |
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Galiè N., Palazzini M., Manes A. Eur Respir J 2010; 36: 986-990 | |
Cystic fibrosis: to ion transport and beyond Bush A., Davies J. Eur Respir J 2010; 36: 991-992 | |
Update on the European Respiratory Review Humbert M. Eur Respir J 2010; 36: 993-994 | |
Prioritised research agenda for prevention and control of chronic respiratory diseases Bousquet J., Kiley J., Bateman E.D., Viegi G., Cruz A.A., Khaltaev N., Aït Khaled N., Baena-Cagnani C.E., Barreto M.L., Billo N., Canonica G.W., Carlsen K-H., Chavannes N., Chuchalin A., Drazen J., Fabbri L.M., Gerbase M.W., Humbert M., Joos G., Masjedi M.R., Makino S., Rabe K., To T., Zhi L. Eur Respir J 2010; 36: 995-1001 | |
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality Lee H.M., Le H., Lee B.T., Lopez V.A., Wong N.D. Eur Respir J 2010; 36: 1002-1006 | |
Adverse respiratory outcomes associated with occupational exposures at a soy processing plant Cummings K.J., Gaughan D.M., Kullman G.J., Beezhold D.H., Green B.J., Blachere F.M., Bledsoe T., Kreiss K., Cox-Ganser J. Eur Respir J 2010; 36: 1007-1015 | |
Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction Heijink I.H., van Oosterhout A., Kapus A. Eur Respir J 2010; 36: 1016-1026 | |
Body composition and plasma levels of inflammatory biomarkers in COPD Eagan T.M.L., Aukrust P., Ueland T., Hardie J.A., Johannessen A., Mollnes T.E., Damås J.K., Bakke P.S., Wagner P.D. Eur Respir J 2010; 36: 1027-1033 | |
Sex-related differences in COPD in five Latin American cities: the PLATINO study Lopez Varela M.V., Montes de Oca M., Halbert R.J., Muiño A., Perez-Padilla R., Tálamo C., Jardim J.R.B., Valdivia G., Pertuzé J., Moreno D., Menezes A.M.B. Eur Respir J 2010; 36: 1034-1041 | |
Efficacy of standard rehabilitation in COPD outpatients with comorbidities Crisafulli E., Gorgone P., Vagaggini B., Pagani M., Rossi G., Costa F., Guarriello V., Paggiaro P., Chetta A., de Blasio F., Olivieri D., Fabbri L.M., Clini E.M. Eur Respir J 2010; 36: 1042-1048 | |
Pulmonary artery pressure limits exercise capacity at high altitude Naeije R., Huez S., Lamotte M., Retailleau K., Neupane S., Abramowicz D., Faoro V. Eur Respir J 2010; 36: 1049-1055 | |
Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing Sommer N., Pak O., Schörner S., Derfuss T., Krug A., Gnaiger E., Ghofrani H.A., Schermuly R.T., Huckstorf C., Seeger W., Grimminger F., Weissmann N. Eur Respir J 2010; 36: 1056-1066 | |
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Kato K., Kataoka K., Ogawa T., Watanabe F., Arizono S. Eur Respir J 2010; 36: 1067-1072 | |
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Luján M., Gallego M., Belmonte Y., Fontanals D., Vallès J., Lisboa T., Rello J. Eur Respir J 2010; 36: 1073-1079 | |
Inhaled drugs as risk factors for community-acquired pneumonia Almirall J., Bolíbar I., Serra-Prat M., Palomera E., Roig J., Hospital I., Carandell E., Agustí M., Ayuso P., Estela A., Torres A. Eur Respir J 2010; 36: 1080-1087 | |
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge Kiss L., Schütte H., Padberg W., Weissmann N., Mayer K., Gessler T., Voswinckel R., Seeger W., Grimminger F. Eur Respir J 2010; 36: 1088-1098 | |
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Tabata C., Hirayama N., Tabata R., Yasumitsu A., Yamada S., Murakami A., Iida S., Tamura K., Fukuoka K., Kuribayashi K., Terada T., Nakano T. Eur Respir J 2010; 36: 1099-1105 | |
Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults Sistonen S., Malmberg P., Malmström K., Haahtela T., Sarna S., Rintala R.J., Pakarinen M.P. Eur Respir J 2010; 36: 1106-1112 | |
Deposition and metabolism of inhaled ciclesonide in the human lung Nave R., Watz H., Hoffmann H., Boss H., Magnussen H. Eur Respir J 2010; 36: 1113-1119 | |
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice Dif F., Wu Y-Z., Burgel P-R., Ollero M., Leduc D., Aarbiou J., Borot F., Garcia-Verdugo I., Martin C., Chignard M., Israel-Biet D., Kita Y., Scholte B.J., Touqui L. Eur Respir J 2010; 36: 1120-1130 | |
Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs Gaschler G.J., Zavitz C.C.J., Bauer C.M.T., Stämpfli M.R. Eur Respir J 2010; 36: 1131-1142 | |
Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor Mortaz E., Adcock I.M., Ito K., Kraneveld A.D., Nijkamp F.P., Folkerts G. Eur Respir J 2010; 36: 1143-1154 | |
Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin Glader P., Smith M.E., Malmhäll C., Balder B., Sjöstrand M., Qvarfordt I., Lindén A. Eur Respir J 2010; 36: 1155-1164 | |
FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction Chen H., Jacobson B.A., Mason L., Wolf S.F., Bowman M.R. Eur Respir J 2010; 36: 1165-1173 | |
Pathophysiology of bronchial smooth muscle remodelling in asthma Bara I., Ozier A., Tunon de Lara J-M., Marthan R., Berger P. Eur Respir J 2010; 36: 1174-1184 | |
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Solovic I., Sester M., Gomez-Reino J.J., Rieder H.L., Ehlers S., Milburn H.J., Kampmann B., Hellmich B., Groves R., Schreiber S., Wallis R.S., Sotgiu G., Schölvinck E.H., Goletti D., Zellweger J.P., Diel R., Carmona L., Bartalesi F., Ravn P., Bossink A., Duarte R., Erkens C., Clark J., Migliori G.B., Lange C. Eur Respir J 2010; 36: 1185-1206 | |
The relationship between sarcoidosis and lymphoma Papanikolaou I.C., Sharma O.P. Eur Respir J 2010; 36: 1207-1219 | |
Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension Gambaryan N., Perros F., Montani D., Cohen-Kaminsky S., Mazmanian G.M., Humbert M. Eur Respir J 2010; 36: 1209-1211 | |
Pulmonary hypertension in a patient with Abt-Letterer-Siwesyndrome and episodes of HAPE Corvinus C., Bärtsch P., Dehnert C., Herth F.J., Grünig E. Eur Respir J 2010; 36: 1212-1214 | |
Pulmonary alveolar proteinosis associated with Epstein-Barr virus infection Edwards C., Primhak R., Cohen M.C. Eur Respir J 2010; 36: 1214-1216 | |
The fear of volcano: short-term health effects after Mount Etna's eruption in 2002 Fano V., Cernigliaro A., Scondotto S., Perucci C.A., Forastiere F. Eur Respir J 2010; 36: 1216-1218 | |
From Paul's predictions in the World Cup to the publication bias in genetic studies on complex traits Zhang G., LeSouëf P.N. Eur Respir J 2010; 36: 1218-1219 | |
Do the current house dust mite-driven models really mimic allergic asthma? Birrell M.A., Van Oosterhout A.J.M., Belvisi M.G. Eur Respir J 2010; 36: 1220-1221 | |
Risk factors of community-acquired pneumonia in children Heiskanen-Kosma T., Korppi M. Eur Respir J 2010; 36: 1221-1222 | |
Vital capacity in lying position: important in Duchenne patients Wijkstra P., Hazenberg A., Nieuwenhuis J. Eur Respir J 2010; 36: 1222 | |
From the authors: Aliverti A., Lo Mauro A., D'Angelo M.G. Eur Respir J 2010; 36: 1223 | |
Errata Errata Eur Respir J 2010; 36: 1224 | |
Eur Respir J 2010; 35: 505–514
Eur Respir J 2010; 36: 1225 | |